Europe Neurodegenerative Disease Market Size, Share & Trends Analysis Report By Disease Indication (Multiple Sclerosis, Parkinson's Disease, Alzheimer's Disease, Others), By Drug Type (Immunomodulator, Vesicular Monoamine Transporter 2 (VMAT2), Others), By Routes of Administration (Oral, Intravenous (IV) delivery, Others) and By Country (U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, Rest of Europ) Forecasts, 2026-2034

Last Updated: August 31, 2026 | Author: Debashree Bora | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Europe Neurodegenerative Disease Market Size Analysis
    1. Introduction
    2. Europe Neurodegenerative Disease Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Multiple Sclerosis
      2. Parkinson's Disease
      3. Alzheimer's Disease
      4. Others
    3. Europe Neurodegenerative Disease Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulator
      2. Vesicular Monoamine Transporter 2 (VMAT2)
      3. Others
    4. Europe Neurodegenerative Disease Market Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intravenous (IV) delivery
      3. Others
  7. Europe Europe Neurodegenerative Disease Market Size Analysis
    1. Introduction
    2. Europe Neurodegenerative Disease Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Multiple Sclerosis
      2. Parkinson's Disease
      3. Alzheimer's Disease
      4. Others
    3. Europe Neurodegenerative Disease Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulator
      2. Vesicular Monoamine Transporter 2 (VMAT2)
      3. Others
    4. Europe Neurodegenerative Disease Market Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intravenous (IV) delivery
      3. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    13. Rest of Europ
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
  8. Competitive Landscape
    1. Europe Neurodegenerative Disease Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  9. Market Players Assessment
    1. Boehringer Ingelheim International GmbH
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Hoffmann-La Roche AG
    3. UCB SA
    4. Novartis International AG
  10. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  11. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  12. Disclaimer

List of Tables

Table 1: Europe Europe Neurodegenerative Disease Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 2: Europe Europe Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 3: Europe Europe Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 4: Europe Europe Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 5: U.K. Europe Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 6: U.K. Europe Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 7: U.K. Europe Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 8: Germany Europe Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 9: Germany Europe Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 10: Germany Europe Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 11: France Europe Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 12: France Europe Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 13: France Europe Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 14: Spain Europe Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 15: Spain Europe Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 16: Spain Europe Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 17: Italy Europe Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 18: Italy Europe Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 19: Italy Europe Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 20: Russia Europe Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 21: Russia Europe Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 22: Russia Europe Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 23: Nordic Europe Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 24: Nordic Europe Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 25: Nordic Europe Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 26: Benelux Europe Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 27: Benelux Europe Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 28: Benelux Europe Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 29: Rest of Europ Europe Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 30: Rest of Europ Europe Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 31: Rest of Europ Europe Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

We are featured on: